Surescripts Health Information Network achieves QHIN designation

Surescripts Health Information Network, a subsidiary of Surescripts, has been designated as a Qualified Health Information Network by the Recognized Coordinating Entity, The Sequoia Project.

As a designated QHIN, Surescripts Health Information Network can now provide access to nationwide health data exchange governed by the Trusted Exchange Framework and Common Agreement policies and technical requirements, joining other designated QHINs.

“We are thrilled that Surescripts Health Information Network has achieved QHIN designation and appreciate the ongoing support of the RCE, The Sequoia Project and the Assistant Secretary for Technology Policy/Office of the National Coordinator for Health Information Technology, in achieving this pivotal milestone,” said Tara Dragert, chief product officer, Surescripts, and president, Surescripts Health Information Network. “As a QHIN, Surescripts Health Information Network will leverage the industry-leading reliability, support, and deep partnership that our parent company, Surescripts, is known for.”

[Read more: Surescripts, Clear release joint case study highlighting collaborative efforts]

Now Surescripts Network Alliance participants have the opportunity to connect to Surescripts Health Information Network, a QHIN, via Interconnect.

“This QHIN designation underscores our purpose – advancing clinical intelligence sharing and amplifying our ability to collaborate and improve healthcare at a greater scale. Together, we’re going places in healthcare as we tackle our shared challenges – and simpler, trusted health intelligence sharing takes us there,” said Frank Harvey, CEO of Surescripts.

“The QHIN designation process is intentionally rigorous to ensure a high bar for the nation’s health information sharing infrastructure,” said Mariann Yeager, CEO of The Sequoia Project and RCE lead. “We’re thrilled to announce Surescripts Health Information Network as our latest QHIN and look forward to expanding TEFCA connectivity.”

[Read more: Surescripts releases 2024 Annual Impact Report]